FDA clears BioE product for processing umbilical cord blood

01/14/2009 | Minneapolis/St. Paul Business Journal

The FDA granted approval to BioE for its PrepaCyte-CB Processing System, which is designed to extract stem cells and other cells with therapeutic potential from umbilical cord blood for use in human transplantation. The company said the product will be distributed right away to private and public cord-blood banks.

View Full Article in:

Minneapolis/St. Paul Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC